- Home
- MTEM
as 12-18-2024 3:37pm EST
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 9.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 15.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.30 - $4.12 | Next Earning Date: | 12-27-2024 |
| Revenue: | $25,470,000 | Revenue Growth: | -49.41% |
| Revenue Growth (this year): | -78.05% | Revenue Growth (next year): | -89.81% |
Stock Insider Trading Activity of Molecular Templates Inc. (MTEM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BIOTECH TARGET N V | MTEM | 10% Owner | Nov 14 '24 | Sell | $0.66 | 1,279,820 | $845,833.04 | 0 |
Latest Molecular Templates Inc. News
MTEM Breaking Stock News: Dive into MTEM Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements
GlobeNewswire
4 months ago
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
Journal-News, Hamilton, Ohio
6 months ago
Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame
Motley Fool
6 months ago
Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
TechCrunch
6 months ago
Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
The Telegraph
6 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
6 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Bloomberg
6 months ago
Saudis Said to Hand About 60% of Aramco Offer to Foreigners
Compare MTEM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MTEM Molecular Templates Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.